These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9516065)

  • 1. Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes.
    Hübler A; Abendroth K; Keiner T; Stöcker W; Kauf E; Hein G; Stein G
    Exp Clin Endocrinol Diabetes; 1998; 106(1):79-84. PubMed ID: 9516065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
    Han HJ; Kang CW; Park SH
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A; Lang CH; Wilson TA
    Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone and visceral manifestations of lipoatrophic diabetes. Apropos of a case].
    de Wazieres B; Wendling D; Fest T; Morin G; Dupond JL
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):761-4. PubMed ID: 1306598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound changes in the GH-IGF-I system in adolescent girls with IDDM: can IGFBP1 be used to reflect overall glucose regulation?
    Halldin MU; Hagenäs L; Tuvemo T; Gustafsson J
    Pediatr Diabetes; 2000 Sep; 1(3):121-30. PubMed ID: 15016222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.
    Zhuang HX; Wuarin L; Fei ZJ; Ishii DN
    J Pharmacol Exp Ther; 1997 Oct; 283(1):366-74. PubMed ID: 9336345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IGF system in metabolism regulation.
    Binoux M
    Diabete Metab; 1995 Dec; 21(5):330-7. PubMed ID: 8586149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
    Hanaire-Broutin H; Sallerin-Caute B; Poncet MF; Tauber M; Bastide R; Rosenfeld R; Tauber JP
    Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful insulin therapy in lipoatrophic diabetes].
    Böhmer K; Hauner H; Phlippen R; Gries FA
    Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: is an immunological mechanism involved?
    Cabrera-Freitag P; Escalada J; Goikoetxea MJ; Laguna S; Sanz ML; Gastaminza G
    J Investig Allergol Clin Immunol; 2011; 21(5):417-9. PubMed ID: 21905513
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy.
    Corvillo F; Aparicio V; López-Lera A; Garrido S; Araújo-Vilar D; de Miguel MP; López-Trascasa M
    Front Immunol; 2018; 9():2142. PubMed ID: 30283460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoatrophic diabetes with acanthosis nigricans. Prolonged blood glucose normalization by continuous infusion of insulin].
    Leblanc H; Jadaud JM; Dejax C; Saltiel H; Passa P
    Presse Med; 1984 Apr; 13(16):987-9. PubMed ID: 6232527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of congenital generalized lipodystrophy with lipoatrophic diabetes developing anti-insulin antibodies.
    Usui H; Makino H; Shikata K; Sugimoto T; Wada J; Yamana J; Matsuda M; Yoneda M; Koshima I
    Diabet Med; 2002 Sep; 19(9):794-5. PubMed ID: 12207821
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent panniculitis associated with generalized lipodystrophy and growth hormone deficiency.
    Hou JW; Huang SF
    J Formos Med Assoc; 2005 Jul; 104(7):518-21. PubMed ID: 16091831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus.
    Peteiro-González D; Fernández-Rodríguez B; Cabezas-Agrícola JM; Araújo-Vilar D
    Diabetes Res Clin Pract; 2011 Mar; 91(3):e61-3. PubMed ID: 21146887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoatrophic diabetes. A therapeutic challenge].
    Martins Ribeiro L; Martins S; João Oliveira M; Cardoso H; Silva Borges T
    An Pediatr (Barc); 2013 Jan; 78(1):54-8. PubMed ID: 22796055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoatrophic diabetes].
    Kusakabe T; Ebihara K; Nakao K
    Nihon Rinsho; 2006 Sep; Suppl 3():110-3. PubMed ID: 17022511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.